29 . Akyuz F, Ibrisim D, Balik E, Yonal O, Kaymakoglu S, Bugra D, Mungan Z . Evaluation of malignancy risk and endoscopic follow up in achalasia : Case report.
32.
In achalasia, there is idiopathic destruction of parasympathetic ganglia of the Auerbach's ( Myenteric ) plexus of the entire esophagus, which results in functional narrowing of the lower esophagus, and peristaltic failure throughout its length.
33.
Dear Dr . Smith : I would like to have any information you have about " Achalasia Esophagitis, " the cause and what can be done for it . _ N . P ., Hobart, Ind.
34.
In contrast, surgery for achalasia is generally accompanied by either a " Dor " or " Toupet " partial fundoplication, which is less likely than a Nissen wrap to aggravate the dysphagia that characterizes achalasia.
35.
In contrast, surgery for achalasia is generally accompanied by either a " Dor " or " Toupet " partial fundoplication, which is less likely than a Nissen wrap to aggravate the dysphagia that characterizes achalasia.
36.
In 2007, Dai Andrews worked with Dr . Sharon Caplan at Johns Hopkins University on a study to determine whether sword swallowing could be used to help patients who suffer from achalasia or those who had suffered severe throat trauma.
37.
Bozta _ G, Mungan Z, �zdil S, Aky�z F, Karaca C, Demir K, Kaymakoglu S, Bes1s1k F, �akaaloglu Y, �kten A . Pneumatic balloon dilatation in primary achalasia : The long term following results.
38.
Often, symptoms that may suggest esophageal spasm are the result of another condition such as gastroesophageal reflux disease ( GERD ) or achalasia . heartburn, globus pharyngis ( which is a feeling that something is stuck in the throat ) or a dry cough.
39.
Autopsy and myotomy specimens have, on histological examination, shown an inflammatory response consisting of CD3 / CD8-positive cytotoxic T lymphocytes, variable numbers of eosinophils and mast cells, loss of ganglion cells, and neurofibrosis; these events appear to occur early in achalasia.
40.
This week, researchers from Johns Hopkins Medical Institutions, led by Dr . Pankaj J . Pasricha, added a disease to the list of problems now treatable with botulinum toxin : achalasia, a relatively rare condition in which muscle spasms in the esophagus prevent food from entering the stomach.
